Pillstats
Rx only · Solution · Oral

Levothyroxine Sodium

Brands: Ermeza · Thyquidity · Tirosint Sol · Levothyroxine Sodium

2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
2 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
ATC
RxCUI (US)
US makers3 labelers
Packages34
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 2 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.447$0.894$1.34$1.79Nov 2025Apr 2026Jun 2026
$1.554
Latest avg · Jun 17, 2026
+0%
Since Nov 19, 2025
2
Active US suppliers
100%
Top-2 supplier share*

Medicaid dispensing volume

No Medicaid utilization on record for this drug concept yet. Quarterly volume (CMS State Drug Utilization Data) loads with the utilization ETL.

Who makes it2 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
IBSA Pharma Inc.unknown30SUPPLYING
Oliva Therapeutics, LLCunknown2SUPPLYING
Viatris Specialty LLCunknown2EXITED 2026

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.